Who owns Mineralys Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of MLYS from SEC Form 13F filings across 220 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 220 institutions disclosed 97.0M shares of Mineralys Therapeutics, Inc. worth $2.42B — about 109% of shares outstanding; the largest disclosed holder is Catalys Pacific, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
220
13F holders
$2.42B
value, 2026 filers
109%
of shares outstanding (97.0M sh)
35
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of MLYS's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Catalys Pacific, LLC | 7.8M | $196.0M | 93.4% | 8.8% | -1.3% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 7.7M | $193.3M | 1.9% | 8.6% | 0.0% |
| 3 | BlackRock, Inc. | 6.2M | $155.1M | 0.0% | 6.9% | +4.8% |
| 4 | SAMSARA BIOCAPITAL, LLC | 5.9M | $147.5M | 14.0% | 6.6% | 0.0% |
| 5 | FMR LLC | 4.7M | $118.4M | 0.0% | 5.3% | +4.5% |
| 6 | DEERFIELD MANAGEMENT COMPANY, L.P. | 4.0M | $99.5M | 1.5% | 4.4% | 0.0% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 3.0M | $74.7M | 0.0% | 3.3% | +7.9% |
| 8 | STATE STREET CORP | 2.9M | $72.3M | 0.0% | 3.2% | -30.5% |
| 9 | Capital World Investors | 2.6M | $64.6M | 0.0% | 2.9% | +28.7% |
| 10 | Laurion Capital Management LP | 2.5M | $62.4M | 1.0% | 2.8% | -1.0% |
| 11 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.1M | $52.0M | 0.0% | 2.3% | -8.5% |
| 12 | ARMISTICE CAPITAL, LLC | 1.8M | $44.4M | 0.5% | 2% | +1.8% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 1.7M | $42.3M | 0.0% | 1.9% | +6.3% |
| 14 | ANDERA PARTNERS | 1.6M | $40.0M | 22.8% | 1.8% | 0.0% |
| 15 | SR ONE CAPITAL MANAGEMENT, LP | 1.6M | $39.3M | 3.4% | 1.8% | 0.0% |
| 16 | FRANKLIN TEMPLETON INC | 1.5M | $25.5M | 0.0% | 1.7% | -8.1% |
| 17 | ORBIMED ADVISORS LLC | 1.5M | $36.6M | 0.7% | 1.6% | -31.1% |
| 18 | Polar Capital Holdings Plc | 1.4M | $35.6M | 0.1% | 1.6% | -0.3% |
| 19 | Pictet Asset Management Holding SA | 1.4M | $34.6M | 0.0% | 1.5% | -3.8% |
| 20 | SPHERA FUNDS MANAGEMENT LTD. | 1.3M | $33.2M | 4.7% | 1.5% | -10.1% |
| 21 | BANK OF AMERICA CORP /DE/ | 1.3M | $32.9M | 0.0% | 1.5% | -13.1% |
| 22 | AMERICAN CENTURY COMPANIES INC | 1.3M | $32.0M | 0.0% | 1.4% | +22.7% |
| 23 | Point72 Asset Management, L.P.NEW | 1.3M | $31.9M | 0.0% | 1.4% | new |
| 24 | Invesco Ltd. | 1.2M | $29.2M | 0.0% | 1.3% | +6.3% |
| 25 | Ghisallo Capital Management LLC | 1.1M | $28.3M | 0.5% | 1.3% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.